Intraocular Lens Stocks List

Intraocular Lens Stocks Recent News

Date Stock Title
Apr 25 STAA Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
Apr 25 NVS Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Apr 25 ANIK Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago
Apr 24 NVS Novartis bags paediatric FDA label expansion for Lutathera
Apr 24 NVS Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Apr 24 NVS Company News for Apr 24, 2024
Apr 24 NVS Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Apr 23 NVS Why Novartis Stock Topped the Market on Tuesday
Apr 23 NVS FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Apr 23 NVS Novartis wins pediatric indication for Lutathera for rare cancer
Apr 23 NVS Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Apr 23 NVS Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock
Apr 23 NVS Novartis AG (NVS) Q1 2024 Earnings Call Transcript
Apr 23 NVS Novartis Stock Jumps After Beating Expectations, Raising Guidance
Apr 23 NVS Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
Apr 23 NVS Novartis raises full-year guidance on Q1 beat, drug sales
Apr 23 NVS How Novartis Rode Two Blockbuster Drugs To Its Beat And Raise, And Three-Day Sprint
Apr 23 NVS Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results
Apr 23 NVS Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Apr 23 NVS Biggest stock movers today: SPOT, GM, DHR, IBRX, NVS, and more
Intraocular Lens

Intraocular lens (IOL) is a lens implanted in the eye as part of a treatment for cataracts or myopia. The most common type of IOL is the pseudophakic IOL. These are implanted during cataract surgery, after the cloudy eye's natural lens (colloquially called a cataract) has been removed. The pseudophakic IOL provides the same light focusing function as the natural crystalline lens. The second type of IOL, more commonly known as a phakic intraocular lens (PIOL), is a lens which is placed over the existing natural lens and is used in refractive surgery to change the eye's optical power as a treatment for myopia (nearsightedness).IOLs usually consist of a small plastic lens with plastic side struts, called haptics, to hold the lens in place in the capsular bag inside the eye. IOLs were conventionally made of an inflexible material (PMMA), although this has largely been superseded by the use of flexible materials, such as silicone and acrylic glass. Most IOLs fitted today are fixed monofocal lenses matched to distance vision. However, other types are available, such as multifocal IOLs that provide the patient with multiple-focused vision at far and reading distance, and adaptive IOLs that provide the patient with limited visual accommodation.
Surgeons annually implant more than 6 million lenses. The procedure can be done under local anesthesia with the patient awake throughout the operation. The use of a flexible IOL enables the lens to be rolled for insertion into the capsule through a very small incision, thus avoiding the need for stitches. This procedure usually takes less than 30 minutes in the hands of an experienced ophthalmologist. The recovery period is about 2–3 weeks. After surgery, patients should avoid strenuous exercise or anything else that significantly increases blood pressure. They should visit their ophthalmologists regularly for several months to monitor the implants.
IOL implantation carries several risks associated with eye surgeries, such as infection, loosening of the lens, lens rotation, inflammation and nighttime halos, but a systematic review of studies has determined that the procedure is safer than conventional laser eye treatment. Though IOLs enable many patients to have reduced dependence on glasses, most patients still rely on glasses for certain activities, such as reading.

Browse All Tags